Ratings: Revolution Starts Strong as The Voice Rises, Bones Up from Finale, Mob Doctor Ailing

Fox Sets Mob Doctor End Date, Pushes Touch Season 2 Back Another Week

The Revolution will be televised — and it will be sampled well.

Leading out of an amplified The Voice (which with 13.4 million total viewers and a 4.6 demo rating was up 9 percent week-to-week) and admittedly facing little competition, NBC’s post-apocalyptic drama drew 11.7 million samplers while netting a 4.1 rating, making it the highest-rated network drama debut in three years (since ABC’s V) and the Peacock’s best drama premiere in five years (since, oof, Bionic Woman).

RELATED | NBC’s Revolution: Are You Signing Up? Plus: Exclusive Scoop on Why the Cubs Didn’t Win this Year’s World Series

NBC also notes that Revolution commanded the best demo rating for any episode of any 10 pm network drama since a January 2010 installment of Private Practice.

Some NBC drama premiere numbers for comparison:
* Smash: 11.4 mil, 3.8 (Monday at 10)
* The Playboy Club: 5 mil, 1.6 (Monday at 10)
* Grimm: 6.5 mil, 2.1 (Friday at 9)

Among Monday’s other fresh fare, Bones returned to an audience of 7.8 million viewers and scored a 2.3 demo rating, up 8 and 21 percent from its May finale though down some from its Monday time slot premiere in April. The Mob Doctor series premiere led out of that with 5 million viewers and a 1.5 rating, demonstrating just 65 percent retention.

Some Fox drama premiere numbers for comparison:
* House final season: 9.8 mil, 3.9
* Alcatraz: 10 mil, 3.3
* Terra Nova: 9.1 mil, 3.1

RELATED | Is Fox’s The Mob Doctor a ‘Hit’? Or a Miss? Cast Your Vote!

What were you tuned into this Monday night? Next week: Dancing With the Stars, CBS’ sitcoms, Castle and Hawaii Five-0 return.


Related stories

Shameless, House of Lies and Californication: Showtime Sets Return Dates, Shares Teasers

Emmys 2012: HBO, Fueled by Game of Thrones, and CBS Lead Early Winners; Smash Pulls Upset

The Castle Premiere: 13 Quick Observations

Get more from TVLine.com: Follow us on Twitter, Facebook, Newsletter